fluconazole has been researched along with Cross Infection in 189 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Cross Infection: Any infection which a patient contracts in a health-care institution.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine whether Candida glabrata colonization and invasive candidiasis (IC) increased among critically ill surgical patients 3 years after the introduction of fluconazole prophylaxis to a surgical intensive care unit (SICU)." | 9.14 | The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial. ( Colantuoni, EA; Fothergill, AW; Hendrix, CW; Lipsett, PA; Magill, SS; Merz, WG; Shields, CE; Swoboda, SM, 2009) |
| "It is clear that echinocandins and fluconazole each have roles in the management of candidemia." | 8.91 | Is Fluconazole or an Echinocandin the Agent of Choice for Candidemia. ( Clancy, CJ; Eschenauer, GA; Nguyen, MH, 2015) |
| "The administration of fluconazole in the ICU setting in dosages of > or = 800 mg/day or > or = 10 mg/kg/day has been reported in about 400 patients with candidiasis of different localisation including candidemia, with a rapidly increasing incidence of serious candidal infections." | 8.80 | [Value of high dosage fluconazole in therapy of candida infections in intensive care medicine]. ( Duswald, KH; Penk, A; Pittrow, L, 1998) |
| " In this patient with severe, chronic polymicrobial spine infection with epidural abscess and CSF fistula due to multidrug-resistant organisms, the cure was achieved with long-term antimicrobial specific therapy with quinupristin-dalfopristin (50 days) and linezolid (100 days) with mild side effects." | 7.73 | Nosocomial spondylodiskitis with epidural abscess and CSF fistula cured with quinupristin/dalfopristin and linezolid. ( Altobelli, G; Belfiori, B; Malincarne, L; Marroni, M; Papili, R; Stagni, G; Tinca, M, 2006) |
| "Candidemia is an increasing problem in tertiary care hospitals worldwide." | 5.43 | Outbreak of candidemia caused by fluconazole resistant Candida parapsilosis strains in an intensive care unit. ( Casulari, LA; Colombo, AL; Damasceno, CM; Pinhati, HM; Siqueira, RA; Souza, AC, 2016) |
| "Anidulafungin was effective in the treatment of patients with documented candidemia arising from different sites, and no significant side effects were observed." | 5.36 | Clinical experience of anidulafungin for the treatment of patients with documented candidemia. ( De Rosa, FG; Falcone, M; Ghezzi, MC; Pasero, D; Raponi, G; Russo, A; Toma, L; Venditti, M, 2010) |
| " krusei breakthrough infections was similar to what is seen with high-dose fluconazole (400 mg) prophylaxis, and no adverse effects of low-dose fluconazole in terms of increased incidence of non-susceptible Candida species was seen." | 5.31 | Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome. ( Henslee-Downey, JP; Mehta, J; Safdar, A; Singhal, S; van Rhee, F, 2001) |
| " The usefulness of fluconazole therapy, the best dosage regimen and the in vitro and in vivo correlations are discussed." | 5.31 | [Candida albicans fungemia with pulmonary localization treated with fluconazole. A case report]. ( Clavier, H; Kalfon, P; Mebtouche, B; Thomas, F, 2000) |
| "To determine whether Candida glabrata colonization and invasive candidiasis (IC) increased among critically ill surgical patients 3 years after the introduction of fluconazole prophylaxis to a surgical intensive care unit (SICU)." | 5.14 | The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial. ( Colantuoni, EA; Fothergill, AW; Hendrix, CW; Lipsett, PA; Magill, SS; Merz, WG; Shields, CE; Swoboda, SM, 2009) |
| "To see whether empirical fluconazole improves clinical outcomes more than placebo in adult ICU patients at high risk for invasive candidiasis." | 5.13 | Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial. ( Biswas, P; Darouiche, RO; Edwards, JE; Hadley, S; Karchmer, AW; Panzer, H; Rex, JH; Schuster, MG; Slotman, G; Sobel, JD, 2008) |
| "Itraconazole was as effective as fluconazole in nosocomial candidiasis in children receiving intensive care and was devoid of serious side effects." | 5.11 | Randomized comparison between fluconazole and itraconazole for the treatment of candidemia in a pediatric intensive care unit: a preliminary study. ( Chakrabarti, A; M, J; Mondal, RK; Singhi, SC, 2004) |
| "To demonstrate whether fluconazole reduces multiple organ failure and mortality in early septic shock (<24 hrs)." | 5.10 | Fluconazole improves survival in septic shock: a randomized double-blind prospective study. ( Al Omar, NF; Jacobs, S; Price Evans, DA; Tariq, M, 2003) |
| "It is clear that echinocandins and fluconazole each have roles in the management of candidemia." | 4.91 | Is Fluconazole or an Echinocandin the Agent of Choice for Candidemia. ( Clancy, CJ; Eschenauer, GA; Nguyen, MH, 2015) |
| " Single-center studies have shown that prophylactic fluconazole reduces the rates of invasive candidiasis and/or colonization of extremely-low-birth-weight infants." | 4.83 | Strategies for prevention of nosocomial sepsis in the neonatal intensive care unit. ( Saiman, L, 2006) |
| "The administration of fluconazole in the ICU setting in dosages of > or = 800 mg/day or > or = 10 mg/kg/day has been reported in about 400 patients with candidiasis of different localisation including candidemia, with a rapidly increasing incidence of serious candidal infections." | 4.80 | [Value of high dosage fluconazole in therapy of candida infections in intensive care medicine]. ( Duswald, KH; Penk, A; Pittrow, L, 1998) |
| " Amphotericin B remains the agent of choice for treatment of hematogenously disseminated candidiasis and for candidemia, although the optimal dosage and duration of this therapy are poorly defined." | 4.78 | Current strategies for treating invasive candidiasis: emphasis on infections in nonneutropenic patients. ( Edwards, JE; Filler, SG, 1992) |
| " Therapeutic usage of amphotericin B, the agent of choice for serious Candida infection, is reviewed, along with usage of 5-flucytosine and fluconazole." | 4.78 | Pathogenesis and management of Candida infection syndromes in non-neutropenic patients. ( Solomkin, JS, 1993) |
| " Fluconazole is the agent of choice for most Candida urinary tract infections." | 3.85 | Comparison of Amphotericin B Bladder Irrigations Versus Fluconazole for the Treatment of Candiduria in Intensive Care Unit Patients. ( Campbell-Bright, S; Caylor, MM; Lin, FC; Sullivan, KA, 2017) |
| " Candida albicans has been the species most often associated with neonatal infections, but recently, there has been a changing pattern in the isolates recovered from neonates with invasive candidiasis, which poses resistance to the existing class of azoles such as fluconazole antifungals along with cross resistance to newer triazoles, which results in a therapeutic challenge in invasive fungal infections causing high incidence of mortality." | 3.81 | Candidemia-induced pediatric sepsis and its association with free radicals, nitric oxide, and cytokine level in host. ( Kumar, A; Kumar, D; Singh, S; Tilak, R, 2015) |
| " In this patient with severe, chronic polymicrobial spine infection with epidural abscess and CSF fistula due to multidrug-resistant organisms, the cure was achieved with long-term antimicrobial specific therapy with quinupristin-dalfopristin (50 days) and linezolid (100 days) with mild side effects." | 3.73 | Nosocomial spondylodiskitis with epidural abscess and CSF fistula cured with quinupristin/dalfopristin and linezolid. ( Altobelli, G; Belfiori, B; Malincarne, L; Marroni, M; Papili, R; Stagni, G; Tinca, M, 2006) |
| "Fluconazole is an antifungal agent that is widely used for the treatment of Candida infection." | 3.73 | Effect of fluconazole consumption on long-term trends in candidal ecology. ( Blot, S; Buyle, F; Claeys, G; De Waele, JJ; Hoste, E; Janssens, R; Peleman, R; Vandewoude, K; Vogelaers, D, 2006) |
| "Empirical fluconazole therapy is reasonable for likelihoods of invasive candidiasis greater than 2." | 3.73 | Empirical anti-Candida therapy among selected patients in the intensive care unit: a cost-effectiveness analysis. ( Golan, Y; Hadley, S; Pauker, SG; Wolf, MP; Wong, JB, 2005) |
| " The patient has no identified sequelae at 6-month follow-up and continues on long-term fluconazole therapy for candida endocarditis." | 3.73 | Survival of candida sepsis in extracorporeal membrane oxygenation. ( Ibsen, LM; Minette, MS, 2005) |
| "Although fungal urinary tract infections are an increasing nosocomial problem, the significance of funguria is still not clear." | 2.69 | Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group. ( Dismukes, WE; Gallis, HA; Karchmer, AW; Kauffman, CA; Lee, JY; Mangi, R; McKinsey, DS; Mosher, A; Sharkey, PK; Sobel, JD; Sugar, AM; Vazquez, JA; Wise, GJ, 2000) |
| "Fungal urinary tract infections are increasingly prevalent in hospitalized patients." | 2.68 | Oral fluconazole for Candida urinary tract infection. ( Castin, A; Moskovitz, B; Nativ, O; Potasman, I; Srugo, I, 1997) |
| "Fluconazole alone was given to 27 patients, amphotericin B alone to 10, and sequential therapy to 6." | 2.68 | Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU. ( Ibáñez-Lucía, P; León-Gil, C; León-Regidor, MA; Martínez-González, J; Nolla-Salas, J; Sitges-Serra, A; Torres-Rodríguez, JM, 1997) |
| "Most patients with sepsis or septic shock from a urinary source have complicated urinary tract infection." | 2.49 | Urinary tract infection. ( Nicolle, LE, 2013) |
| "Candidemia is a serious condition associated with high morbidity and mortality and increased healthcare costs in pediatric patients." | 2.47 | Candida infections in non-neutropenic children after the neonatal period. ( Celebi, S; Hacimustafaoglu, M, 2011) |
| "Invasive candidiasis is a common nosocomial infection among critically ill patients, constitutes an important cause of sepsis, and is associated with significant morbidity and mortality." | 2.44 | Invasive candidiasis in the ICU: evidence based and on the edge of evidence. ( Hollenbach, E, 2008) |
| " This article reviews recent pertinent data with regard to dosing guidelines, efficacy, and toxicities of available systemic antifungal agents in the newborn." | 2.42 | Antifungal pharmacotherapy for neonatal candidiasis. ( Bliss, JM; Gigliotti, F; Wellington, M, 2003) |
| "Invasive fungal infections have been noted in increasing frequency in immunosuppressed patients and may be due to organisms that are less susceptible or frankly resistant to antifungal agents." | 2.41 | Fungal susceptibility testing: where are we now? ( Patterson, TF, 2002) |
| "krusei fungemia from our cancer institute." | 2.40 | Nosocomial Candida krusei fungemia in cancer patients: report of 10 cases and review. ( Grausova, S; Grey, E; Krcmery, V; Krupova, I; Kunova, A; Mateicka, F; Pichnova, E; Sabo, A; Spanik, S; Trupl, J, 1999) |
| "Fluconazole resistance was found in 248 (38." | 1.91 | Screening of C. auris among Candida isolates from various tertiary care institutions in Lahore by VITEK 2 and real time PCR based molecular technique. ( Amar, A; Arshad, F; Huma, ZE; Imran, M; Jabeen, K; Saleem, S, 2023) |
| "The fluconazole therapy was replaced with micafungin on day 26 and the patient exhibited improvements." | 1.56 | Case report: nosocomial fungemia caused by Candida diddensiae. ( Choi, YJ; Jung, SI; Kim, SE; Park, KH; Shin, JH; Won, EJ, 2020) |
| "Candidemia was diagnosed: 5." | 1.46 | [Epidemiology, species, antifungal resistance and outcome of candidemia in a university hospital in Buenos Aires, Argentina for 16 years]. ( Farías, L; Fernández, NB; García, S; Pozzi, NC; Tiraboschi, IN, 2017) |
| "Surveillance of candidemia is essential to monitor trends in species distribution and change in the incidence and antifungal resistance." | 1.46 | Epidemiology and cost implications of candidemia, a 6-year analysis from a developing country. ( Alp, E; Cevahir, F; Ture, Z; Ulu Kilic, A; Yozgat, N, 2017) |
| "Candidemia is an increasing problem in tertiary care hospitals worldwide." | 1.43 | Outbreak of candidemia caused by fluconazole resistant Candida parapsilosis strains in an intensive care unit. ( Casulari, LA; Colombo, AL; Damasceno, CM; Pinhati, HM; Siqueira, RA; Souza, AC, 2016) |
| "Once candidemia is found, ophthalmologic examination and systemic antifungal therapy are needed." | 1.38 | [A study for candidemia during the six year period from 1993 to 1999 in St. Luke's International Hospital]. ( Furukawa, K; Kazama, I, 2012) |
| "Prior use of fluconazole, severe respiratory failure and hospitalization time are associated with IPA in patients with chronic pneumopathies with respiratory isolation of Aspergillus spp." | 1.38 | [Clinical factors associated with invasive pulmonary aspergillosis in patients with chronic pneumopathies and respiratory isolation of Aspergillus spp]. ( Casal, M; Castón, JJ; Linares, MJ; Rivero, A; Torre-Cisneros, J, 2012) |
| "Fluconazole was more frequently used in medium size hospitals than in the large ones (60." | 1.38 | [Trends in systemic antifungal use in critically ill patients. Multicenter observational study, 2006-2010]. ( Alvarez-Lerma, F; Gimeno-Costa, R; Gracia-Arnillas, MP; Insausti-Ordeñana, J; López-Pueyo, MJ; Olaechea-Astigarraga, PM; Otal-Entraigas, JJ; Palomar-Martínez, M; Seijas-Betolaza, I, 2012) |
| "Fluconazole resistance was a rare finding in our study." | 1.37 | Species distribution and in vitro fluconazole susceptibility of clinical Candida isolates in a Brazilian tertiary-care hospital over a 3-year period. ( França, EJ; Furlaneto, MC; Furlaneto-Maia, L; Oda, S; Oliveira, MT; Quesada, RM; Rodrigues, R; Rota, JF; Serpa, R, 2011) |
| "Fluconazole was the most common agent prescribed for the treatment of candidaemia." | 1.37 | Epidemiology and management of candidaemia--a retrospective, multicentre study in five hospitals in the UK. ( Bal, AM; Chalmers, C; Chew, J; Gaur, S; Gould, IM; Kumar, A; Leanord, A; Mathur, S; Wan, WY; Wright, T, 2011) |
| "Candida bloodstream infections are associated with high intensive care unit and hospital mortality rates and resource use." | 1.37 | Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study. ( Azoulay, E; Echeverria, PM; Kett, DH; Vincent, JL, 2011) |
| "Anidulafungin was effective in the treatment of patients with documented candidemia arising from different sites, and no significant side effects were observed." | 1.36 | Clinical experience of anidulafungin for the treatment of patients with documented candidemia. ( De Rosa, FG; Falcone, M; Ghezzi, MC; Pasero, D; Raponi, G; Russo, A; Toma, L; Venditti, M, 2010) |
| "Fluconazole has been a new option for treatment however, expanded use of the drug brought up the development of resistance." | 1.36 | [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species]. ( Akman, I; Altuncu, E; Bakır, M; Bilgen, H; Cerikçioğlu, N; Ilki, A; Ozek, E; Ulger, N, 2010) |
| "glabrata fungemia were systematically recorded." | 1.36 | Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients. ( Adrie, C; Clec'h, C; Cohen, Y; Gauzit, R; Karoubi, P; Marsepoil, T; Zarka, D, 2010) |
| "Fluconazole was the most commonly administered antimicrobial, followed by the echinocandins, and amphotericin B products were infrequently administered." | 1.35 | Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. ( Anaissie, EJ; Chang, CH; Fishman, JA; Horn, DL; Marr, KA; Neofytos, D; Olyaei, AJ; Pfaller, MA; Steinbach, WJ; Webster, KM, 2009) |
| "Candida infection is a relatively common cause of nosocomial bloodstream infection in immunosuppressed patients." | 1.35 | [Candidemia and granulomatous tubulointerstitial nephritis]. ( Benoit, G; Faucher, C; Madore, F; Mandalenakis, N, 2008) |
| "Fluconazole (Diflucan R) was administered for 28 days at a dose of 6 mg/kg every third day during the first week and daily after the first week." | 1.33 | Fluconazole prophylaxis prevents invasive fungal infection in high-risk, very low birth weight infants. ( Bertini, G; Dani, C; Filippi, L; Perugi, S; Pratesi, S; Rubaltelli, FF, 2005) |
| "Fluconazole was the most frequently prescribed antifungal (1846 patient-days) followed by amphotericin B deoxycholate (251 patient-days), lipid formulations of amphotericin B (201 patient-days), itraconazole (71 patient-days), and caspofungin (42 patient-days)." | 1.33 | Evaluation of antifungals in the surgical intensive care unit: a multi-institutional study. ( Bearden, DT; Cannon, JP; Garey, KW; Gentry, LO; Kontoyiannis, DP; Lewis, RE; Neuhauser, MM, 2006) |
| "Fluconazole resistance was detected in one isolate of C." | 1.33 | Epidemiology of candidemia in a Turkish tertiary care hospital. ( Bakir, M; Barton, R; Cerikcioglu, N; Yagci, A, 2006) |
| "Fluconazole resistance was infrequent." | 1.32 | Prevalence and fluconazole susceptibility of Candida species recovered from the oropharynx of healthcare workers (HCWs) and non-HCWs. ( Klein, JD; Levin, S, 2004) |
| "Fluconazole was the antifungal agent most frequently used, both in infected and colonized patients." | 1.32 | [Indications for antifungal treatment in intensive care unit patients]. ( Alvarez-Lerma, F; Bermejo, B; Cerdá, E; León, C; Olaechea, P; Palomar, M, 2004) |
| "The isolation of Candida sp in nosocomial infections is on the increase and over the past 10 years many guidelines for "good" practices and recommendations have been published on the modalities for the management of systemic candidiasis." | 1.32 | [Infections by Candida sp. in intensive care. Survey of French practices]. ( Blin, P; Chevalier, E; Cohen, Y; Dupont, H; Gauzit, R; Hennequin, C; Montravers, P; Palestro, B; Timsit, JF; Veber, B, 2003) |
| " The usefulness of fluconazole therapy, the best dosage regimen and the in vitro and in vivo correlations are discussed." | 1.31 | [Candida albicans fungemia with pulmonary localization treated with fluconazole. A case report]. ( Clavier, H; Kalfon, P; Mebtouche, B; Thomas, F, 2000) |
| "Diagnosis and treatment of fungal infections in medical and surgical intensive care units are controversial issues." | 1.31 | [Fungal infections in intensive care units: a cross-survey]. ( Dupont, H, 2001) |
| " krusei breakthrough infections was similar to what is seen with high-dose fluconazole (400 mg) prophylaxis, and no adverse effects of low-dose fluconazole in terms of increased incidence of non-susceptible Candida species was seen." | 1.31 | Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome. ( Henslee-Downey, JP; Mehta, J; Safdar, A; Singhal, S; van Rhee, F, 2001) |
| "Fluconazole was used before the onset of candidemia in only two patients." | 1.31 | Nosocomial candidemia in a tertiary care hospital in Saudi Arabia. ( Bukharie, HA, 2002) |
| "Fluconazole seems to be an effective and well-tolerated agent in the treatment of severe life-threatening systemic candidiasis, and a very good alternative to amphotericin B, in cardiac surgery patients." | 1.30 | Systemic candidiasis in cardiac surgery patients. ( Geroulanos, S; Kriaras, J; Michalopoulos, A, 1997) |
| "This dermatomycosis is an infrequent nosocomial infection in adults, which to our knowledge has not been previously reported." | 1.30 | An epidemic outbreak of Malassezia folliculitis in three adult patients in an intensive care unit: a previously unrecognized nosocomial infection. ( Archer-Dubon, C; Baez-Martinez, R; Icaza-Chivez, ME; Orozco-Topete, R; Ponce de León, S; Reyes, E, 1999) |
| "(NAC) in a single National Cancer Institution within 10 years were analysed for aetiology, risk factors and outcome." | 1.30 | Nosocomial candidaemias due to species other than Candida albicans in cancer patients. Aetiology, risk factors, and outcome of 45 episodes within 10 years in a single cancer institution. ( Grey, E; Jurga, L; Krcmery, V; Kunova, A; Mardiak, J; Mateicka, F; Mrazova, M; Novotny, J; Sabo, A; Sevcikova, L; Sorkovska, D; Sufliarsky, J; Trupl, J; West, D, 1999) |
| "Fluconazole was administered to these patients for a mean of 20 days at doses ranging from 100 to 200 mg/d." | 1.28 | Treatment of candidemia in critically ill surgical patients with intravenous fluconazole. ( León, C; Martín, E; Nolla-Salas, J; Sitges-Serra, A; Torres-Rodríguez, JM, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 39 (20.63) | 18.2507 |
| 2000's | 84 (44.44) | 29.6817 |
| 2010's | 55 (29.10) | 24.3611 |
| 2020's | 11 (5.82) | 2.80 |
| Authors | Studies |
|---|---|
| da Matta, VL | 1 |
| de Souza Carvalho Melhem, M | 1 |
| Colombo, AL | 3 |
| Moretti, ML | 1 |
| Rodero, L | 1 |
| Duboc de Almeida, GM | 1 |
| dos Anjos Martins, M | 1 |
| Costa, SF | 2 |
| Souza Dias, MB | 1 |
| Nucci, M | 2 |
| Levin, AS | 2 |
| Bai, Y | 1 |
| Zheng, Z | 1 |
| Liu, T | 1 |
| Yan, Z | 1 |
| Du, M | 1 |
| Yao, H | 1 |
| Liu, Y | 1 |
| Suo, J | 1 |
| Ramtin, M | 1 |
| Sharifniya, F | 1 |
| Larypoor, M | 1 |
| Mirpour, M | 1 |
| Zarrabi, S | 1 |
| Asadzadeh, M | 1 |
| Ahmad, S | 2 |
| Al-Sweih, N | 2 |
| Khan, Z | 2 |
| Oladele, RO | 1 |
| Ettu, AO | 1 |
| Medugu, N | 1 |
| Habib, A | 1 |
| Egbagbe, E | 1 |
| Osinaike, T | 1 |
| Makanjuola, OB | 1 |
| Ogunbosi, B | 1 |
| Irowa, OO | 1 |
| Ejembi, J | 1 |
| Uwaezuoke, NS | 1 |
| Adeleke, G | 1 |
| Mutiu, B | 1 |
| Ogunsola, F | 1 |
| Rotimi, V | 1 |
| Huma, ZE | 1 |
| Saleem, S | 1 |
| Imran, M | 1 |
| Jabeen, K | 1 |
| Arshad, F | 1 |
| Amar, A | 1 |
| Ong, CW | 1 |
| Chen, SC | 3 |
| Clark, JE | 1 |
| Halliday, CL | 1 |
| Kidd, SE | 1 |
| Marriott, DJ | 1 |
| Marshall, CL | 1 |
| Morris, AJ | 1 |
| Morrissey, CO | 1 |
| Roy, R | 1 |
| Slavin, MA | 1 |
| Stewardson, AJ | 1 |
| Worth, LJ | 1 |
| Heath, CH | 1 |
| Salazar-Leal, JI | 1 |
| Ramírez-Montelongo, SM | 1 |
| López Luis, BA | 1 |
| Alfouzan, W | 1 |
| Joseph, L | 1 |
| Stolarska, M | 1 |
| Gucwa, K | 1 |
| Urbańczyk-Lipkowska, Z | 1 |
| Andruszkiewicz, R | 1 |
| Ahangarkani, F | 1 |
| Shokohi, T | 1 |
| Rezai, MS | 1 |
| Ilkit, M | 1 |
| Mahmoodi Nesheli, H | 1 |
| Karami, H | 1 |
| Tamaddoni, A | 1 |
| Alizadeh-Navaei, R | 1 |
| Khodavaisy, S | 1 |
| Meis, JF | 2 |
| Badali, H | 1 |
| Rojas, AE | 1 |
| Pérez, JE | 1 |
| Hernández, JS | 1 |
| Zapata, Y | 1 |
| Kim, SE | 1 |
| Jung, SI | 1 |
| Park, KH | 1 |
| Choi, YJ | 1 |
| Won, EJ | 1 |
| Shin, JH | 1 |
| Fattouh, N | 1 |
| Hdayed, D | 1 |
| Geukgeuzian, G | 1 |
| Tokajian, S | 1 |
| Khalaf, RA | 1 |
| De Francesco, MA | 1 |
| Piccinelli, G | 1 |
| Gelmi, M | 1 |
| Gargiulo, F | 1 |
| Ravizzola, G | 1 |
| Pinsi, G | 1 |
| Peroni, L | 1 |
| Bonfanti, C | 1 |
| Caruso, A | 1 |
| Liu, WL | 1 |
| Lai, CC | 1 |
| Li, MC | 1 |
| Wu, CJ | 1 |
| Ko, WC | 1 |
| Hung, YL | 1 |
| Tang, HJ | 1 |
| Hsueh, PR | 2 |
| Lu, M | 1 |
| Yu, C | 1 |
| Cui, X | 1 |
| Shi, J | 1 |
| Yuan, L | 1 |
| Sun, S | 1 |
| Tiraboschi, IN | 1 |
| Pozzi, NC | 1 |
| Farías, L | 1 |
| García, S | 1 |
| Fernández, NB | 1 |
| Mazari, W | 1 |
| Boucherit-Otmani, Z | 2 |
| El Haci, IA | 1 |
| Ilahi, A | 1 |
| Boucherit, K | 2 |
| Öncü, B | 1 |
| Belet, N | 1 |
| Emecen, AN | 1 |
| Birinci, A | 1 |
| Dreyfuss, D | 1 |
| Ricard, JD | 1 |
| Gaudry, S | 1 |
| Trpković, A | 1 |
| Pekmezović, M | 1 |
| Barać, A | 1 |
| Crnčević Radović, L | 1 |
| Arsić Arsenijević, V | 1 |
| Ahmad, KM | 1 |
| Ishchuk, OP | 1 |
| Hellborg, L | 1 |
| Jørgensen, G | 1 |
| Skvarc, M | 1 |
| Stenderup, J | 1 |
| Jørck-Ramberg, D | 1 |
| Polakova, S | 1 |
| Piškur, J | 1 |
| Nicolle, LE | 1 |
| Xiao, M | 3 |
| Wang, H | 3 |
| Lu, J | 3 |
| Kong, F | 3 |
| Ma, XJ | 2 |
| Xu, YC | 3 |
| De Rosa, FG | 2 |
| Motta, I | 1 |
| Corcione, S | 1 |
| Cattel, F | 1 |
| Di Perri, G | 1 |
| D'Avolio, A | 1 |
| Tyczkowska-Sieron, E | 1 |
| Gaszynski, W | 1 |
| Tyczkowski, J | 1 |
| Glowacka, A | 1 |
| Baptista, MI | 1 |
| Nona, J | 1 |
| Ferreira, M | 1 |
| Sampaio, I | 1 |
| Abrantes, M | 1 |
| Tomé, MT | 1 |
| Neto, MT | 1 |
| Barroso, R | 1 |
| Serelha, M | 1 |
| Virella, D | 1 |
| Kumar, D | 1 |
| Kumar, A | 3 |
| Singh, S | 1 |
| Tilak, R | 1 |
| Ferreira, D | 1 |
| Grenouillet, F | 2 |
| Blasco, G | 2 |
| Samain, E | 1 |
| Hénon, T | 1 |
| Dussaucy, A | 1 |
| Millon, L | 2 |
| Mercier, M | 1 |
| Pili-Floury, S | 1 |
| Seddiki, SM | 1 |
| Kunkel, D | 1 |
| Eschenauer, GA | 2 |
| Nguyen, MH | 1 |
| Clancy, CJ | 1 |
| Neufeld, PM | 1 |
| Melhem, Mde S | 1 |
| Szeszs, MW | 1 |
| Ribeiro, MD | 1 |
| Amorim, Ede L | 1 |
| da Silva, M | 1 |
| Lazéra, Mdos S | 1 |
| Bergamo, VZ | 1 |
| Balbueno, EA | 1 |
| Hatwig, C | 1 |
| Pippi, B | 1 |
| Dalla Lana, DF | 1 |
| Donato, RK | 1 |
| Schrekker, HS | 1 |
| Fuentefria, AM | 1 |
| Sullivan, KA | 1 |
| Caylor, MM | 1 |
| Lin, FC | 1 |
| Campbell-Bright, S | 1 |
| Fernandez Rodriguez, B | 1 |
| Peña Gonzalez, L | 1 |
| Calvo, MC | 1 |
| Chaves Sanchez, F | 1 |
| Pallas Alonso, CR | 1 |
| de Alba Romero, C | 1 |
| Zhang, L | 1 |
| Kudinha, T | 1 |
| Chu, YZ | 2 |
| Kang, M | 1 |
| Sun, ZY | 2 |
| Li, RY | 1 |
| Liao, K | 2 |
| Zou, GL | 2 |
| Fan, X | 1 |
| Pinhati, HM | 1 |
| Casulari, LA | 1 |
| Souza, AC | 1 |
| Siqueira, RA | 1 |
| Damasceno, CM | 1 |
| Ulu Kilic, A | 1 |
| Alp, E | 1 |
| Cevahir, F | 1 |
| Ture, Z | 1 |
| Yozgat, N | 1 |
| Benoit, G | 1 |
| Mandalenakis, N | 1 |
| Faucher, C | 1 |
| Madore, F | 1 |
| Playford, EG | 1 |
| Marriott, D | 1 |
| Nguyen, Q | 1 |
| Chen, S | 1 |
| Ellis, D | 1 |
| Slavin, M | 1 |
| Sorrell, TC | 1 |
| Schuster, MG | 1 |
| Edwards, JE | 3 |
| Sobel, JD | 3 |
| Darouiche, RO | 1 |
| Karchmer, AW | 3 |
| Hadley, S | 3 |
| Slotman, G | 1 |
| Panzer, H | 1 |
| Biswas, P | 1 |
| Rex, JH | 1 |
| Fekete, T | 1 |
| Hollenbach, E | 1 |
| Saha, R | 1 |
| Das Das, S | 1 |
| Kaur, IR | 1 |
| Shelburne, SA | 1 |
| Lee, DH | 1 |
| Girão, E | 1 |
| Basso, M | 1 |
| Gobara, S | 1 |
| Gomes, LB | 1 |
| Medeiros, EA | 1 |
| Magill, SS | 1 |
| Swoboda, SM | 1 |
| Shields, CE | 1 |
| Colantuoni, EA | 1 |
| Fothergill, AW | 1 |
| Merz, WG | 1 |
| Lipsett, PA | 1 |
| Hendrix, CW | 1 |
| Lam, SW | 1 |
| Carver, PL | 1 |
| Horn, DL | 1 |
| Neofytos, D | 1 |
| Anaissie, EJ | 1 |
| Fishman, JA | 1 |
| Steinbach, WJ | 1 |
| Olyaei, AJ | 1 |
| Marr, KA | 1 |
| Pfaller, MA | 9 |
| Chang, CH | 1 |
| Webster, KM | 1 |
| Zilberberg, MD | 1 |
| Kothari, S | 1 |
| Shorr, AF | 1 |
| Borges Sá, M | 1 |
| Garnacho Montero, J | 1 |
| Manzoni, P | 2 |
| Mostert, M | 2 |
| Jacqz-Aigrain, E | 2 |
| Farina, D | 2 |
| Cohen, Y | 2 |
| Karoubi, P | 1 |
| Adrie, C | 1 |
| Gauzit, R | 2 |
| Marsepoil, T | 1 |
| Zarka, D | 1 |
| Clec'h, C | 1 |
| Toltzis, P | 1 |
| Walsh, M | 1 |
| Lyon, GM | 1 |
| Karatela, S | 1 |
| Sunay, S | 1 |
| Adiri, Y | 1 |
| Rodríguez, D | 1 |
| Almirante, B | 1 |
| Cuenca-Estrella, M | 1 |
| Rodríguez-Tudela, JL | 1 |
| Mensa, J | 1 |
| Ayats, J | 1 |
| Sanchez, F | 1 |
| Pahissa, A | 1 |
| Altuncu, E | 1 |
| Bilgen, H | 1 |
| Cerikçioğlu, N | 2 |
| Ilki, A | 1 |
| Ulger, N | 1 |
| Bakır, M | 2 |
| Akman, I | 1 |
| Ozek, E | 1 |
| Lortholary, O | 2 |
| Desnos-Ollivier, M | 1 |
| Sitbon, K | 1 |
| Fontanet, A | 1 |
| Bretagne, S | 1 |
| Dromer, F | 1 |
| Kett, DH | 1 |
| Azoulay, E | 1 |
| Echeverria, PM | 1 |
| Vincent, JL | 1 |
| Falcone, M | 1 |
| Russo, A | 1 |
| Pasero, D | 1 |
| Toma, L | 1 |
| Raponi, G | 1 |
| Ghezzi, MC | 1 |
| Venditti, M | 1 |
| Takakura, S | 1 |
| O'Connell, K | 1 |
| Lyons, M | 1 |
| Hanahoe, B | 1 |
| Cormican, M | 1 |
| Iatta, R | 1 |
| Caggiano, G | 1 |
| Cuna, T | 1 |
| Montagna, MT | 1 |
| Chalmers, C | 1 |
| Gaur, S | 1 |
| Chew, J | 1 |
| Wright, T | 1 |
| Mathur, S | 1 |
| Wan, WY | 1 |
| Gould, IM | 1 |
| Leanord, A | 1 |
| Bal, AM | 1 |
| Mitrokhin, SD | 1 |
| Sokolov, AA | 1 |
| Bassetti, M | 2 |
| Taramasso, L | 1 |
| Nicco, E | 1 |
| Molinari, MP | 2 |
| Mussap, M | 1 |
| Viscoli, C | 2 |
| Yenigün Koçak, B | 1 |
| Kuloğlu, F | 1 |
| Doğan Çelik, A | 1 |
| Akata, F | 1 |
| Hacimustafaoglu, M | 1 |
| Celebi, S | 1 |
| Ozhak-Baysan, B | 1 |
| Ogunc, D | 1 |
| Colak, D | 1 |
| Ongut, G | 1 |
| Donmez, L | 1 |
| Vural, T | 1 |
| Gunseren, F | 1 |
| Furlaneto, MC | 1 |
| Rota, JF | 1 |
| Quesada, RM | 1 |
| Furlaneto-Maia, L | 1 |
| Rodrigues, R | 1 |
| Oda, S | 1 |
| Oliveira, MT | 1 |
| Serpa, R | 1 |
| França, EJ | 1 |
| Negri, M | 1 |
| Silva, S | 1 |
| Henriques, M | 1 |
| Oliveira, R | 1 |
| Kaldau, NC | 1 |
| Brorson, S | 1 |
| Jensen, PE | 1 |
| Schultz, C | 1 |
| Arpi, M | 1 |
| Gardner, AH | 1 |
| Prodhan, P | 1 |
| Stovall, SH | 1 |
| Gossett, JM | 1 |
| Stern, JE | 1 |
| Wilson, CD | 1 |
| Fiser, RT | 1 |
| Olaechea-Astigarraga, PM | 1 |
| Alvarez-Lerma, F | 2 |
| Palomar-Martínez, M | 1 |
| Insausti-Ordeñana, J | 1 |
| López-Pueyo, MJ | 1 |
| Seijas-Betolaza, I | 1 |
| Otal-Entraigas, JJ | 1 |
| Gimeno-Costa, R | 1 |
| Gracia-Arnillas, MP | 1 |
| Ben-Ami, R | 1 |
| Rahav, G | 1 |
| Elinav, H | 1 |
| Kassis, I | 1 |
| Shalit, I | 1 |
| Gottesman, T | 1 |
| Megged, O | 1 |
| Weinberger, M | 1 |
| Ciobotaro, P | 1 |
| Shitrit, P | 1 |
| Weber, G | 1 |
| Paz, A | 1 |
| Miron, D | 1 |
| Oren, I | 1 |
| Bishara, J | 1 |
| Block, C | 1 |
| Keller, N | 1 |
| Kontoyiannis, DP | 2 |
| Giladi, M | 1 |
| Shao, HF | 1 |
| Yan, Y | 1 |
| Fan, H | 1 |
| Hu, ZD | 1 |
| Hu, TS | 1 |
| Ni, YX | 1 |
| Castón, JJ | 1 |
| Linares, MJ | 1 |
| Rivero, A | 1 |
| Casal, M | 1 |
| Torre-Cisneros, J | 1 |
| Kazama, I | 1 |
| Furukawa, K | 1 |
| De Luca, D | 1 |
| Stronati, M | 1 |
| Ruffinazzi, G | 1 |
| Luparia, M | 1 |
| Tavella, E | 1 |
| Boano, E | 1 |
| Castagnola, E | 1 |
| Oberoi, JK | 1 |
| Wattal, C | 1 |
| Goel, N | 1 |
| Raveendran, R | 1 |
| Datta, S | 1 |
| Prasad, K | 1 |
| Zer, Y | 1 |
| Balci, I | 1 |
| Meriç, G | 1 |
| Garbino, J | 2 |
| Kolarova, L | 1 |
| Rohner, P | 1 |
| Lew, D | 1 |
| Pichna, P | 1 |
| Pittet, D | 3 |
| Wroblewska, MM | 1 |
| Swoboda-Kopec, E | 1 |
| Rokosz, A | 1 |
| Krawczyk, E | 1 |
| Marchel, H | 1 |
| Luczak, M | 1 |
| Patterson, TF | 2 |
| Teng, LJ | 1 |
| Yang, PC | 1 |
| Ho, SW | 1 |
| Luh, KT | 2 |
| Calandra, T | 2 |
| Marchetti, O | 2 |
| Dupont, H | 2 |
| Hennequin, C | 1 |
| Montravers, P | 2 |
| Timsit, JF | 1 |
| Veber, B | 1 |
| Chevalier, E | 1 |
| Blin, P | 1 |
| Palestro, B | 1 |
| Snydman, DR | 1 |
| Chen, YC | 1 |
| Chang, SC | 1 |
| Hsieh, WC | 1 |
| Silva, V | 1 |
| Zepeda, G | 1 |
| Alvareda, D | 1 |
| Jacobs, S | 1 |
| Price Evans, DA | 1 |
| Tariq, M | 1 |
| Al Omar, NF | 1 |
| Gudlaugsson, O | 1 |
| Gillespie, S | 1 |
| Lee, K | 1 |
| Vande Berg, J | 1 |
| Hu, J | 1 |
| Messer, S | 1 |
| Herwaldt, L | 1 |
| Pfaller, M | 1 |
| Diekema, D | 1 |
| Leone, M | 1 |
| Albanèse, J | 1 |
| Antonini, F | 1 |
| Michel-Nguyen, A | 1 |
| Blanc-Bimar, MC | 1 |
| Martin, C | 1 |
| Schelenz, S | 1 |
| Gransden, WR | 1 |
| Bliss, JM | 1 |
| Wellington, M | 1 |
| Gigliotti, F | 1 |
| Kaufman, D | 2 |
| Bille, J | 1 |
| Fluckiger, U | 1 |
| Eggimann, P | 1 |
| Ruef, C | 1 |
| Glauser, MP | 1 |
| Täuber, MG | 1 |
| Yang, YL | 1 |
| Ho, YA | 1 |
| Cheng, HH | 1 |
| Ho, M | 1 |
| Lo, HJ | 1 |
| Klein, JD | 1 |
| Levin, S | 1 |
| Chen, YH | 1 |
| Yao, WZ | 1 |
| Wang, JL | 1 |
| Palomar, M | 1 |
| León, C | 2 |
| Olaechea, P | 1 |
| Cerdá, E | 1 |
| Bermejo, B | 1 |
| Kobayashi, CC | 1 |
| de Fernandes, OF | 1 |
| Miranda, KC | 1 |
| de Sousa, ED | 1 |
| Silva, Mdo R | 1 |
| Mondal, RK | 1 |
| Singhi, SC | 1 |
| Chakrabarti, A | 1 |
| M, J | 1 |
| Piarroux, R | 1 |
| Balvay, P | 1 |
| Tran, V | 1 |
| Boillot, A | 1 |
| Ostrosky-Zeichner, L | 1 |
| Braun, JP | 1 |
| Schneider, M | 1 |
| Dohmen, P | 1 |
| Döpfmer, U | 1 |
| Sanguinetti, M | 1 |
| Posteraro, B | 1 |
| Fiori, B | 1 |
| Ranno, S | 1 |
| Torelli, R | 1 |
| Fadda, G | 1 |
| Doğan, A | 1 |
| Irmak, H | 1 |
| Harman, M | 1 |
| Ceylan, A | 1 |
| Akpinar, F | 1 |
| Tosun, N | 1 |
| Bertini, G | 1 |
| Perugi, S | 1 |
| Dani, C | 1 |
| Filippi, L | 1 |
| Pratesi, S | 1 |
| Rubaltelli, FF | 1 |
| Luzzati, R | 1 |
| Allegranzi, B | 1 |
| Antozzi, L | 1 |
| Masala, L | 1 |
| Pegoraro, E | 1 |
| Azzini, A | 1 |
| Concia, E | 1 |
| Lin, MY | 1 |
| Carmeli, Y | 2 |
| Zumsteg, J | 1 |
| Flores, EL | 1 |
| Tolentino, J | 1 |
| Sreeramoju, P | 1 |
| Weber, SG | 1 |
| Minette, MS | 1 |
| Ibsen, LM | 1 |
| Jabbour, K | 1 |
| Golan, Y | 2 |
| Wolf, MP | 1 |
| Pauker, SG | 1 |
| Wong, JB | 1 |
| Fanaroff, AA | 1 |
| Aquino, VR | 1 |
| Lunardi, LW | 1 |
| Goldani, LZ | 1 |
| Barth, AL | 1 |
| Righi, E | 1 |
| Costa, A | 1 |
| Fasce, R | 1 |
| Rosso, R | 1 |
| Pallavicini, FB | 1 |
| Saiman, L | 2 |
| Cheng, YR | 1 |
| Lin, LC | 1 |
| Young, TG | 1 |
| Liu, CE | 1 |
| Chen, CH | 1 |
| Tsay, RW | 1 |
| Fridkin, SK | 1 |
| Edwards, JR | 1 |
| Shetty, S | 1 |
| Horan, T | 1 |
| Garey, KW | 1 |
| Neuhauser, MM | 1 |
| Bearden, DT | 1 |
| Cannon, JP | 1 |
| Lewis, RE | 1 |
| Gentry, LO | 1 |
| Blot, S | 1 |
| Janssens, R | 1 |
| Claeys, G | 1 |
| Hoste, E | 1 |
| Buyle, F | 1 |
| De Waele, JJ | 1 |
| Peleman, R | 1 |
| Vogelaers, D | 1 |
| Vandewoude, K | 1 |
| Zaragoza, R | 1 |
| Pemán, J | 1 |
| Marroni, M | 1 |
| Tinca, M | 1 |
| Belfiori, B | 1 |
| Altobelli, G | 1 |
| Malincarne, L | 1 |
| Papili, R | 1 |
| Stagni, G | 1 |
| Barton, R | 1 |
| Yagci, A | 1 |
| Etienne, M | 1 |
| Caron, F | 1 |
| Kalavsky, E | 1 |
| Kisac, P | 1 |
| Huttova, M | 1 |
| Benca, J | 1 |
| Krcmery, V | 7 |
| Marol, S | 1 |
| Yücesoy, M | 1 |
| Méndez-Tovar, LJ | 1 |
| Manzano-Gayosso, P | 1 |
| Velásquez-Hernández, V | 1 |
| Millan-Chiu, B | 1 |
| Hernández-Hernández, F | 1 |
| Mondragón-González, R | 1 |
| López-Martínez, R | 1 |
| Chow, JK | 1 |
| Ruthazer, R | 1 |
| Lichtenberg, D | 1 |
| Chawla, V | 1 |
| Young, J | 1 |
| Zingg, W | 1 |
| Posfay-Barbe, KM | 1 |
| Isaacs, D | 1 |
| Krcmery, S | 1 |
| Masar, O | 1 |
| Messer, SA | 5 |
| Hollis, RJ | 3 |
| Solomkin, JS | 1 |
| Dubé, MP | 1 |
| Heseltine, PN | 1 |
| Rinaldi, MG | 2 |
| Evans, S | 1 |
| Zawacki, B | 1 |
| Nomura, J | 1 |
| Ruskin, J | 1 |
| Nassoura, Z | 1 |
| Ivatury, RR | 1 |
| Simon, RJ | 1 |
| Jabbour, N | 1 |
| Stahl, WM | 1 |
| Saxen, H | 1 |
| Virtanen, M | 1 |
| Carlson, P | 1 |
| Hoppu, K | 1 |
| Pohjavuori, M | 1 |
| Vaara, M | 1 |
| Vuopio-Varkila, J | 1 |
| Peltola, H | 1 |
| Cormican, MG | 1 |
| D'Antonio, D | 1 |
| Mazzoni, A | 1 |
| Iacone, A | 1 |
| Violante, B | 1 |
| Capuani, MA | 1 |
| Schioppa, F | 1 |
| Romano, F | 1 |
| Bregenzer, T | 1 |
| Evison-Eckstein, AC | 1 |
| Frei, R | 1 |
| Zimmerli, W | 1 |
| Voss, A | 1 |
| Kluytmans, JA | 1 |
| Koeleman, JG | 1 |
| Spanjaard, L | 1 |
| Vandenbroucke-Grauls, CM | 1 |
| Verbrugh, HA | 1 |
| Vos, MC | 1 |
| Weersink, AY | 1 |
| Hoogkamp-Korstanje, JA | 1 |
| Nolla-Salas, J | 2 |
| Sitges-Serra, A | 2 |
| León-Gil, C | 1 |
| Martínez-González, J | 1 |
| León-Regidor, MA | 1 |
| Ibáñez-Lucía, P | 1 |
| Torres-Rodríguez, JM | 2 |
| al Soub, H | 1 |
| Estinoso, W | 1 |
| Zhang, J | 1 |
| Michalopoulos, A | 1 |
| Kriaras, J | 1 |
| Geroulanos, S | 1 |
| Schwab, U | 1 |
| Chernomas, F | 1 |
| Larcom, L | 1 |
| Weems, J | 1 |
| Potasman, I | 1 |
| Castin, A | 1 |
| Moskovitz, B | 1 |
| Srugo, I | 1 |
| Nativ, O | 1 |
| Muñoz García de Paredes, P | 1 |
| Oravcova, E | 1 |
| Spanik, S | 2 |
| Mrazova-Studena, M | 1 |
| Trupl, J | 3 |
| Kunova, A | 3 |
| Stopkova-Grey, K | 1 |
| Kukuckova, E | 1 |
| Krupova, I | 2 |
| Demitrovicova, A | 1 |
| Kralovicova, K | 1 |
| Launay, O | 1 |
| Bouges-Michel, C | 1 |
| Jarrousse, B | 1 |
| Bentata, M | 1 |
| Guillevin, L | 1 |
| Houston, A | 1 |
| Rangel-Frausto, MS | 1 |
| Wiblin, T | 1 |
| Blumberg, HM | 1 |
| Jarvis, W | 1 |
| Martin, MA | 1 |
| Neu, HC | 1 |
| Patterson, JE | 1 |
| Dibb, JC | 1 |
| Roldan, CM | 1 |
| Wenzel, RP | 3 |
| Jones, RN | 2 |
| Edmond, MB | 2 |
| Ferré, A | 1 |
| Domingo, P | 1 |
| Alonso, C | 1 |
| Franquet, T | 1 |
| Gurguí, M | 1 |
| Verger, G | 1 |
| Fowler, SL | 1 |
| Rhoton, B | 1 |
| Springer, SC | 1 |
| Lockhart, SR | 1 |
| Pujol, C | 1 |
| Swails-Wenger, JA | 1 |
| Soll, DR | 1 |
| Duswald, KH | 1 |
| Pittrow, L | 1 |
| Penk, A | 2 |
| Berrouane, YF | 1 |
| Herwaldt, LA | 1 |
| Alva, EM | 1 |
| Khayr, W | 1 |
| Grausova, S | 1 |
| Mateicka, F | 3 |
| Pichnova, E | 1 |
| Grey, E | 2 |
| Sabo, A | 2 |
| Archer-Dubon, C | 1 |
| Icaza-Chivez, ME | 1 |
| Orozco-Topete, R | 1 |
| Reyes, E | 1 |
| Baez-Martinez, R | 1 |
| Ponce de León, S | 1 |
| Mrazova, M | 1 |
| Mardiak, J | 1 |
| Jurga, L | 2 |
| Sufliarsky, J | 1 |
| Sevcikova, L | 1 |
| Sorkovska, D | 1 |
| West, D | 1 |
| Novotny, J | 1 |
| Gubbins, PO | 1 |
| McConnell, SA | 1 |
| Penzak, SR | 1 |
| Kauffman, CA | 1 |
| Vazquez, JA | 1 |
| Gallis, HA | 1 |
| McKinsey, DS | 1 |
| Sugar, AM | 1 |
| Sharkey, PK | 1 |
| Wise, GJ | 1 |
| Mangi, R | 1 |
| Mosher, A | 1 |
| Lee, JY | 1 |
| Dismukes, WE | 1 |
| Rocco, TR | 1 |
| Reinert, SE | 1 |
| Simms, HH | 1 |
| Prasad, KN | 1 |
| Agarwal, J | 1 |
| Dixit, AK | 1 |
| Tiwari, DP | 1 |
| Dhole, TN | 1 |
| Ayyagari, A | 1 |
| Thomas, F | 1 |
| Mebtouche, B | 1 |
| Clavier, H | 1 |
| Kalfon, P | 1 |
| Salonen, JH | 1 |
| Richardson, MD | 1 |
| Gallacher, K | 1 |
| Issakainen, J | 1 |
| Helenius, H | 1 |
| Lehtonen, OP | 1 |
| Nikoskelainen, J | 1 |
| Geldner, G | 1 |
| Ruhnke, M | 1 |
| Lepper, P | 1 |
| Wiedeck, H | 1 |
| Essig, A | 1 |
| Trautmann, M | 1 |
| Baddley, JW | 1 |
| Smith, AM | 1 |
| Moser, SA | 1 |
| Pappas, PG | 1 |
| Sulcová, M | 1 |
| Kovacicova, G | 1 |
| Hanzen, J | 1 |
| Pisarcikova, M | 1 |
| Sejnova, D | 1 |
| Horn, J | 1 |
| Babela, R | 1 |
| Svetlansky, I | 1 |
| Lovaszova, M | 1 |
| Gogova, M | 1 |
| Safdar, A | 1 |
| van Rhee, F | 1 |
| Henslee-Downey, JP | 1 |
| Singhal, S | 1 |
| Mehta, J | 1 |
| Kam, LW | 1 |
| Lin, JD | 1 |
| Sypula, WT | 1 |
| Kale-Pradhan, PB | 1 |
| Hope, W | 1 |
| Morton, A | 1 |
| Eisen, DP | 1 |
| Bukharie, HA | 1 |
| Harms, K | 1 |
| Herting, E | 1 |
| Schiffmann, JH | 1 |
| Speer, CP | 1 |
| Filler, SG | 1 |
| Martín, E | 1 |
| Tausch, I | 1 |
| Pertschy, J | 1 |
| Reinke, P | 1 |
| Ziegler-Böhme, H | 1 |
36 reviews available for fluconazole and Cross Infection
| Article | Year |
|---|---|
Diagnosis, management and prevention of Candida auris in hospitals: position statement of the Australasian Society for Infectious Diseases.
Topics: Age Factors; Antifungal Agents; Australia; Candida; Candidiasis; Cross Infection; Disease Transmissi | 2019 |
Urinary tract infection.
Topics: Acute Disease; Aminoglycosides; Amphotericin B; Anti-Infective Agents; Antifungal Agents; Catheters, | 2013 |
Anidulafungin versus fluconazole: clinical focus on IDSA and ESCMID guidelines.
Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Cross Infection; Echinocandins; Europe; Fluc | 2014 |
Is Fluconazole or an Echinocandin the Agent of Choice for Candidemia.
Topics: Adult; Aged; Antifungal Agents; Candida; Candidemia; Cost-Benefit Analysis; Cross Infection; Disease | 2015 |
Invasive candidiasis in the ICU: evidence based and on the edge of evidence.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Deoxycholic Acid; Drug Com | 2008 |
Evolving role of early antifungals in the adult intensive care unit.
Topics: Adult; Antifungal Agents; Candidiasis; Cross Infection; Female; Fluconazole; Hospital Mortality; Hum | 2009 |
[Role of anidulafungin in critically ill patients].
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Critical Il | 2008 |
The use of fluconazole in neonatal intensive care units.
Topics: Antifungal Agents; Candidiasis; Cross Infection; Evidence-Based Medicine; Fluconazole; Humans; Infan | 2009 |
Recently tested strategies to reduce nosocomial infections in the neonatal intensive care unit.
Topics: Anti-Infective Agents; Communicable Disease Control; Cross Infection; Fluconazole; Hand Disinfection | 2010 |
[Candidosis].
Topics: Antifungal Agents; Candidiasis; Catheters; Contraindications; Cross Infection; Disease Susceptibilit | 2011 |
Candida infections in non-neutropenic children after the neonatal period.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Catheter-Related Infections; Child; Cross In | 2011 |
Insights into Candida tropicalis nosocomial infections and virulence factors.
Topics: Antifungal Agents; Candida tropicalis; Candidiasis; Cross Infection; Drug Resistance, Fungal; Flucon | 2012 |
Bilateral polymicrobial osteomyelitis with Candida tropicalis and Candida krusei: a case report and an updated literature review.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida tropicalis; Cross Infection; Drug Combinations; | 2012 |
Prevention of nosocomial infections in neonatal intensive care units.
Topics: Anti-Infective Agents; Central Venous Catheters; Contraindications; Cross Infection; Fluconazole; Hi | 2013 |
Fungal susceptibility testing: where are we now?
Topics: Antifungal Agents; Candida; Candidiasis, Oral; Cross Infection; Dose-Response Relationship, Drug; Dr | 2002 |
Antifungal pharmacotherapy for neonatal candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Cross Infection; Echinocandins; Flucona | 2003 |
Strategies for prevention of neonatal invasive candidiasis.
Topics: Antifungal Agents; Candidiasis; Chemoprevention; Cross Infection; Fluconazole; Fungemia; Humans; Inf | 2003 |
[Diagnosis and treatment of pulmonary fungal infection in intensive care unit].
Topics: Antifungal Agents; Candida; Cross Infection; Fluconazole; Humans; Intensive Care Units; Lung Disease | 2004 |
Clinical consequences of resistant Candida infections in intensive care.
Topics: Antibiotic Prophylaxis; Antifungal Agents; Candidiasis; Cross Infection; Drug Resistance, Fungal; Fl | 2006 |
Strategies for prevention of nosocomial sepsis in the neonatal intensive care unit.
Topics: Antifungal Agents; Candidiasis; Catheterization, Central Venous; Cross Infection; Emollients; Flucon | 2006 |
Invasive fungal infections in critically ill patients: different therapeutic options and a uniform strategy.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Critical Illness; Cross Infection; Deoxycholic Acid; | 2006 |
[Management of fungal urinary tract infections].
Topics: Aged; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Cross Infection; Cystitis; D | 2007 |
Healthcare-associated infections in neonates.
Topics: Anti-Bacterial Agents; Antifungal Agents; Communicable Diseases; Cross Infection; Disease Outbreaks; | 2008 |
Fungal prophylaxis in very low birth weight neonates: nystatin, fluconazole or nothing?
Topics: Administration, Oral; Antifungal Agents; Cross Infection; Fluconazole; Humans; Infant, Newborn; Infa | 2008 |
Pathogenesis and management of Candida infection syndromes in non-neutropenic patients.
Topics: Amphotericin B; Candidiasis; Clinical Trials as Topic; Cross Infection; Fluconazole; Flucytosine; Fu | 1993 |
Epidemiology of candidiasis.
Topics: Antifungal Agents; Candida; Candidiasis; Cross Infection; Drug Resistance, Microbial; Female; Flucon | 1995 |
[Value of high dosage fluconazole in therapy of candida infections in intensive care medicine].
Topics: Antifungal Agents; Candidiasis; Cross Infection; Dose-Response Relationship, Drug; Drug Administrati | 1998 |
Nosocomial Candida krusei fungemia in cancer patients: report of 10 cases and review.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Female; Fluco | 1999 |
Current management of funguria.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cross Infection; Female; Fluconazole; Humans; Male; | 1999 |
Role of newer azoles in surgical patients.
Topics: Antifungal Agents; Azoles; Candidiasis; Cross Infection; Dose-Response Relationship, Drug; Drug Desi | 1999 |
Epidemiology and treatment of hematogenous candidiasis: a Brazilian perspective.
Topics: Amphotericin B; Antifungal Agents; Brazil; Candida; Candidiasis; Cross Infection; Fluconazole; Funge | 2000 |
Candiduria in hospitalized patients: a review.
Topics: Antifungal Agents; Candida; Candidiasis; Cross Infection; Fluconazole; Humans; Hypericum; Plants, Me | 2000 |
Nosocomial fungemia due to amphotericin B-resistant Candida spp. in three pediatric patients after previous neurosurgery for brain tumors.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Brain Neoplasms; Candida; Candidiasis; Catheterizatio | 2001 |
Management of systemic candidal infections in the intensive care unit.
Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Candidiasis; Cross Infection; Drug Resist | 2002 |
Therapeutic dilemma of fluconazole prophylaxis in intensive care.
Topics: Antifungal Agents; Critical Care; Cross Infection; Fluconazole; Humans; Mycoses; Risk Factors | 2002 |
Current strategies for treating invasive candidiasis: emphasis on infections in nonneutropenic patients.
Topics: Amphotericin B; Animals; Candidiasis; Cross Infection; Fluconazole; Fungemia; Humans | 1992 |
11 trials available for fluconazole and Cross Infection
| Article | Year |
|---|---|
Oral care in a neonatal intensive care unit.
Topics: Amphotericin B; Anti-Bacterial Agents; Birth Weight; Chemoprevention; Cross Infection; Female; Fluco | 2017 |
Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial.
Topics: Adult; Aged; Antifungal Agents; Candidiasis; Critical Care; Cross Infection; Double-Blind Method; Fe | 2008 |
The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial.
Topics: Academic Medical Centers; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida gla | 2009 |
[Modern antifungals in therapy of nosocomial mycosis in oncologic patients].
Topics: Antifungal Agents; Candida; Candidiasis, Invasive; Cross Infection; Drug Resistance, Fungal; Female; | 2011 |
Fluconazole improves survival in septic shock: a randomized double-blind prospective study.
Topics: Adult; Aged; Antifungal Agents; Cross Infection; Double-Blind Method; Female; Fluconazole; Hospital | 2003 |
Candiduria in hospital patients: a study prospective.
Topics: Antifungal Agents; Candida; Candidiasis; Colony Count, Microbial; Cross Infection; Female; Fluconazo | 2004 |
Randomized comparison between fluconazole and itraconazole for the treatment of candidemia in a pediatric intensive care unit: a preliminary study.
Topics: Antifungal Agents; Candidiasis; Child; Child, Preschool; Cross Infection; Double-Blind Method; Femal | 2004 |
Candiduria as an early marker of disseminated infection in critically ill surgical patients: the role of fluconazole therapy.
Topics: Adult; Aged; Amphotericin B; Bacterial Infections; Candidiasis; Cause of Death; Colony Count, Microb | 1993 |
Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; APACHE; Candidiasis; | 1997 |
Oral fluconazole for Candida urinary tract infection.
Topics: Administration, Oral; Aged; Antifungal Agents; Candidiasis; Cross Infection; Female; Fluconazole; Hu | 1997 |
Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Catheterization; Cross Infection; Female; F | 2000 |
142 other studies available for fluconazole and Cross Infection
| Article | Year |
|---|---|
Antifungal drug susceptibility profile of Pichia anomala isolates from patients presenting with nosocomial fungemia.
Topics: Amphotericin B; Antifungal Agents; Cross Infection; Fluconazole; Fungemia; Humans; Itraconazole; Mic | 2007 |
Epidemiological Characteristics and Drug Resistance of Fungemia in General Hospitals from 2010 to 2019.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; China; Cross Infection; Drug Resistance, | 2021 |
Evaluation of the Active Ingredient of Campsis radicans Essential Oils and its Antimicrobial Evaluation Against Pathogenic Bacteria.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Cefixime; Cross Infection; Fluconazole; Guai | 2022 |
Molecular fingerprinting by multi-locus sequence typing identifies microevolution and nosocomial transmission of
Topics: Aged; Amphotericin B; Candida; Candida glabrata; Cross Infection; Fluconazole; Humans; Kuwait; Multi | 2023 |
Antibiotic Guidelines for Critically Ill Patients in Nigeria.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Clavulanic Acid; Community-Acqu | 2023 |
Screening of C. auris among Candida isolates from various tertiary care institutions in Lahore by VITEK 2 and real time PCR based molecular technique.
Topics: Antifungal Agents; Candida; Candidiasis; Cross Infection; Fluconazole; Hospitals, Teaching; Humans; | 2023 |
Clinical significance of nosocomial
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Cross Infection; Cryptococcosis; Cryptococcus; Fe | 2019 |
Candida auris in various hospitals across Kuwait and their susceptibility and molecular basis of resistance to antifungal drugs.
Topics: Antifungal Agents; Candida; Candidemia; Candidiasis; Cross Infection; Drug Resistance, Fungal; Fluco | 2020 |
Peptide dendrimers as antifungal agents and carriers for potential antifungal agent-N
Topics: Anti-Infective Agents; Antifungal Agents; Candida albicans; Cell Proliferation; Cross Infection; Den | 2020 |
Epidemiological features of nosocomial candidaemia in neonates, infants and children: A multicentre study in Iran.
Topics: Adolescent; Antifungal Agents; Candida; Candida albicans; Candidemia; Child; Child, Preschool; Cross | 2020 |
Quantitative analysis of the expression of fluconazole-resistant genes in strains of Candida albicans isolated from elderly people at their admission in an intensive care unit in Manizales, Colombia
Topics: Aged; Candida albicans; Candidiasis; Carrier Proteins; Colombia; Colony Count, Microbial; Cross Infe | 2020 |
Case report: nosocomial fungemia caused by Candida diddensiae.
Topics: Anti-Bacterial Agents; Antifungal Agents; Candida; Central Venous Catheters; Cross Infection; DNA, R | 2020 |
Molecular mechanism of fluconazole resistance and pathogenicity attributes of Lebanese Candida albicans hospital isolates.
Topics: Amino Acid Substitution; Animals; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Cell W | 2021 |
Invasive Candidiasis in Brescia, Italy: Analysis of Species Distribution and Antifungal Susceptibilities During Seven Years.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candidiasis, | 2017 |
Clinical manifestations of candidemia caused by uncommon Candida species and antifungal susceptibility of the isolates in a regional hospital in Taiwan, 2007-2014.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Azoles; Candida; Candida glabrata; Candidemia; Ca | 2019 |
Gentamicin synergises with azoles against drug-resistant Candida albicans.
Topics: Animals; Antifungal Agents; Biofilms; Candida albicans; Cross Infection; Drug Resistance, Fungal; Dr | 2018 |
[Epidemiology, species, antifungal resistance and outcome of candidemia in a university hospital in Buenos Aires, Argentina for 16 years].
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Antifungal Agents; Argentina; Candida; | 2017 |
Risk assessment for the spread of Candida sp. in dental chair unit waterlines using molecular techniques.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida; Cross Infection; Dental Equipment; Drug Resist | 2018 |
Health care-associated invasive Candida infections in children.
Topics: Amphotericin B; Candida; Candidiasis, Invasive; Child; Child, Preschool; Cross Infection; Drug Resis | 2019 |
Amphotericin B deoxycholate for candidiasis in intensive care unit patients revisited: medical, ethical, and financial implications.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Creatinine; Critical Illness; Cross Infection; Deoxy | 2013 |
In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cerebrospinal Fluid; Cross | 2012 |
Small chromosomes among Danish Candida glabrata isolates originated through different mechanisms.
Topics: Antifungal Agents; Base Sequence; Candida glabrata; Candidiasis; Chromosomes, Fungal; Cross Infectio | 2013 |
Three clustered cases of candidemia caused by Candida quercitrusa and mycological characteristics of this novel species.
Topics: Adult; Antifungal Agents; Candida; Candidemia; China; Cross Infection; Fluconazole; Hospitals; Human | 2014 |
Analysis of the relationship between fluconazole consumption and non-C. albicans Candida infections.
Topics: Adult; Candida; Candidiasis; Cross Infection; Drug Utilization; Fluconazole; Humans; Incidence; Inte | 2014 |
Invasive fungal infection in neonatal intensive care units: a multicenter survey.
Topics: Amphotericin B; Antifungal Agents; Cross Infection; Drug Resistance, Fungal; Female; Fluconazole; Ge | 2016 |
Candidemia-induced pediatric sepsis and its association with free radicals, nitric oxide, and cytokine level in host.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Candida; Candidemia; Candidiasis; Child; Child, Presc | 2015 |
Outcomes associated with routine systemic antifungal therapy in critically ill patients with Candida colonization.
Topics: Adult; Aged; Antifungal Agents; Candida; Candidiasis; Critical Care Outcomes; Critical Illness; Cros | 2015 |
[Fungal infectivities of implanted catheters due to Candida sp. Biofilms formation and resistance].
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida; Catheter-Related Infections; Catheters, Indwel | 2015 |
Nosocomial candidiasis in Rio de Janeiro State: Distribution and fluconazole susceptibility profile.
Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Cross Infection; Disk Diffusion Antimicrobial Tests | 2015 |
1-n-Hexadecyl-3-methylimidazolium methanesulfonate and chloride salts with effective activities against Candida tropicalis biofilms.
Topics: Anti-Infective Agents; Antifungal Agents; Biofilms; Candida tropicalis; Catheter-Related Infections; | 2015 |
Comparison of Amphotericin B Bladder Irrigations Versus Fluconazole for the Treatment of Candiduria in Intensive Care Unit Patients.
Topics: Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Cross Infection; | 2017 |
Investigation of an unrecognized large-scale outbreak of Candida parapsilosis sensu stricto fungaemia in a tertiary-care hospital in China.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida parapsilosis; Candidemia; China; Cross In | 2016 |
Outbreak of candidemia caused by fluconazole resistant Candida parapsilosis strains in an intensive care unit.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Brazil; Candida; Candidemia; Cross Infection; Cro | 2016 |
Epidemiology and cost implications of candidemia, a 6-year analysis from a developing country.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candida albicans; Candida gl | 2017 |
[Candidemia and granulomatous tubulointerstitial nephritis].
Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis; Cross Infection; Female; Fluconazole; Human | 2008 |
Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp.
Topics: Antifungal Agents; Australia; Candidiasis; Cross Infection; Drug Resistance, Fungal; Female; Flucona | 2008 |
The answer is in: fluconazole prophylaxis is not beneficial for intensive care unit patients without neutropenia.
Topics: Antifungal Agents; Candidiasis; Critical Care; Cross Infection; Fluconazole; Fungemia; Humans; Inten | 2008 |
Pattern of Candida isolates in hospitalized children.
Topics: Antifungal Agents; Candida; Candidiasis; Child; Child, Hospitalized; Child, Preschool; Cross Infecti | 2008 |
Empirical use of fluconazole in critically ill patients: good study, but what was the hold-up?
Topics: Antifungal Agents; Candidiasis; Critical Care; Cross Infection; Fluconazole; Humans; Publishing; Ran | 2009 |
Empirical use of fluconazole in critically ill patients: good study, but what was the hold-up?
Topics: Antifungal Agents; Candidiasis; Critical Care; Cross Infection; Fluconazole; Humans; Publishing; Ran | 2009 |
Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Brazil; Candidiasis; Caspofungin; Chi | 2008 |
Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candidiasis; | 2009 |
Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected ICU-acquired candidemia among patients with sepsis: a model simulation.
Topics: Antifungal Agents; Candidiasis; Cost-Benefit Analysis; Cross Infection; Decision Trees; Drug Costs; | 2009 |
Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients.
Topics: Adult; Aged; Antifungal Agents; Candida glabrata; Candidiasis; Cohort Studies; Critical Care; Critic | 2010 |
Antifungal susceptibility testing of Candida isolates from the Candida surveillance study.
Topics: Antifungal Agents; Candida; Candidiasis; Cross Infection; Echinocandins; Fluconazole; Humans; Microb | 2010 |
Predictors of candidaemia caused by non-albicans Candida species: results of a population-based surveillance in Barcelona, Spain.
Topics: Adult; Age Factors; Aged; Antifungal Agents; Candida; Candidemia; Cross Infection; Female; Fluconazo | 2010 |
[Neonatal Candida infections and the antifungal susceptibilities of the related Candida species].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Drug Resistance, Fungal; F | 2010 |
Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients.
Topics: Adult; Antifungal Agents; Candida; Candida albicans; Candidemia; Caspofungin; Child; Child, Preschoo | 2011 |
Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study.
Topics: Aged; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Cross Infection; Echinocandins; | 2011 |
Clinical experience of anidulafungin for the treatment of patients with documented candidemia.
Topics: Anidulafungin; Antifungal Agents; Candida; Candidemia; Catheters, Indwelling; Cross Infection; Echin | 2010 |
Antifungal susceptibility testing and candidaemia at a tertiary referral hospital.
Topics: Antifungal Agents; Candidemia; Cross Infection; Female; Fluconazole; Humans; Male; Microbial Sensiti | 2011 |
Antifungal susceptibility testing of a 10-year collection of Candida spp. isolated from patients with candidemia.
Topics: Antifungal Agents; Candida; Candidemia; Cross Infection; Drug Resistance, Fungal; Fluconazole; Hospi | 2011 |
Epidemiology and management of candidaemia--a retrospective, multicentre study in five hospitals in the UK.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candidemia; Catheter-Related | 2011 |
Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy.
Topics: Aged; Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Communicable Disease Control; Cro | 2011 |
[Evaluation of epidemiological characteristics and risk factors of candidemia in adult patients in a tertiary-care hospital].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidemia; Case-Control Studies; Cat | 2011 |
Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candidiasis; Child; Child, P | 2012 |
Species distribution and in vitro fluconazole susceptibility of clinical Candida isolates in a Brazilian tertiary-care hospital over a 3-year period.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Cross Infection; Drug Resistance, Fungal; Female; Fl | 2011 |
Fungal infections and antifungal prophylaxis in pediatric cardiac extracorporeal life support.
Topics: Antifungal Agents; Arkansas; Cardiac Surgical Procedures; Chi-Square Distribution; Cross Infection; | 2012 |
[Trends in systemic antifungal use in critically ill patients. Multicenter observational study, 2006-2010].
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Community-Acquired Infections; Critical Illness; Cro | 2012 |
Distribution of fluconazole-resistant Candida bloodstream isolates among hospitals and inpatient services in Israel.
Topics: Adult; Aged; Antifungal Agents; Candida; Candida glabrata; Candidemia; Cross Infection; Drug Resista | 2013 |
In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study.
Topics: Antifungal Agents; China; Cross Infection; Drug Resistance, Fungal; Epidemiological Monitoring; Fluc | 2012 |
[Clinical factors associated with invasive pulmonary aspergillosis in patients with chronic pneumopathies and respiratory isolation of Aspergillus spp].
Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Asthma; Bacterial Infections; Carrier State | 2012 |
[A study for candidemia during the six year period from 1993 to 1999 in St. Luke's International Hospital].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Central Venous Catheters; Cross Infection; F | 2012 |
Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Fluconazole; Flucytosine; | 2012 |
Identification and antifungal susceptibility of Candida isolated from intensive care unit patients.
Topics: Antifungal Agents; Candida; Candidiasis; Cross Infection; Female; Fluconazole; Flucytosine; Humans; | 2002 |
Secular trends of candidemia over 12 years in adult patients at a tertiary care hospital.
Topics: Adolescent; Adult; Age Distribution; Aged; Antifungal Agents; Candidiasis; Causality; Comorbidity; C | 2002 |
Epidemiology of clinical isolates of Candida albicans and their susceptibility to triazoles.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Cross Infection; Drug Resistance, Fungal; Fluconaz | 2002 |
Emergence of nosocomial candidemia at a teaching hospital in Taiwan from 1981 to 2000: increased susceptibility of Candida species to fluconazole.
Topics: Antifungal Agents; Candida; Candidiasis; Cloning, Molecular; Cross Infection; Drug Utilization; Fluc | 2002 |
Antifungal prophylaxis for intensive care unit patients: let's fine tune it.
Topics: Antifungal Agents; Candidiasis; Critical Illness; Cross Infection; Fluconazole; Humans; Intensive Ca | 2002 |
[Infections by Candida sp. in intensive care. Survey of French practices].
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Cross-Sectional Stu | 2003 |
Shifting patterns in the epidemiology of nosocomial Candida infections.
Topics: Antifungal Agents; Candida glabrata; Candidiasis; Cross Infection; Fluconazole; Humans; Incidence; S | 2003 |
Stable susceptibility of Candida blood isolates to fluconazole despite increasing use during the past 10 years.
Topics: Antifungal Agents; Candida; Candidiasis; Cross Infection; Fluconazole; Humans; Microbial Sensitivity | 2003 |
[Nosocomial urinary infection due to Trichosporon asahii. First two cases in Chile].
Topics: Amphotericin B; Antifungal Agents; Chile; Communicable Diseases, Emerging; Cross Infection; Drug Res | 2003 |
Attributable mortality of nosocomial candidemia, revisited.
Topics: Age Factors; Antifungal Agents; Candida; Candidiasis; Cohort Studies; Cross Infection; Female; Fluco | 2003 |
Long-term epidemiological survey of Candida species: comparison of isolates found in an intensive care unit and in conventional wards.
Topics: Antifungal Agents; Candida; Candidiasis; Cross Infection; Female; Fluconazole; France; Hospital Mort | 2003 |
Candidaemia in a London teaching hospital: analysis of 128 cases over a 7-year period.
Topics: Antifungal Agents; Brain Abscess; Candidiasis; Cross Infection; Drug Resistance, Fungal; Endocarditi | 2003 |
Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000.
Topics: Antifungal Agents; Candidiasis; Cross Infection; Data Collection; Drug Resistance, Microbial; Flucon | 2004 |
Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida tropicalis; Candidiasis; Cross Infection; Drug R | 2004 |
Prevalence and fluconazole susceptibility of Candida species recovered from the oropharynx of healthcare workers (HCWs) and non-HCWs.
Topics: Allied Health Personnel; Antifungal Agents; Candida albicans; Cross Infection; Fluconazole; Humans; | 2004 |
[Indications for antifungal treatment in intensive care unit patients].
Topics: Antifungal Agents; APACHE; Candidiasis; Comorbidity; Critical Care; Cross Infection; Fluconazole; Fu | 2004 |
Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients.
Topics: Adult; Age Distribution; Aged; APACHE; Candidiasis; Case-Control Studies; Chi-Square Distribution; C | 2004 |
Prophylaxis or preemptive therapy of invasive candidiasis in the intensive care unit?
Topics: Candidiasis; Case-Control Studies; Critical Care; Cross Infection; Female; Fluconazole; Fungemia; Hu | 2004 |
Successful treatment of dilative cardiomyopathy in a 12-year-old girl using the calcium sensitizer levosimendan after weaning from mechanical biventricular assist support.
Topics: Anti-Bacterial Agents; Antifungal Agents; Calcium; Candidiasis; Cardiomyopathy, Dilated; Cardiotonic | 2004 |
Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Candida glabrata; Candidiasis; Cloning | 2005 |
[Tibial osteomyelitis following intraosseous infusion: a case report].
Topics: Antifungal Agents; Candidiasis; Cross Infection; Diagnosis, Differential; Female; Fluconazole; Human | 2004 |
Fluconazole prophylaxis prevents invasive fungal infection in high-risk, very low birth weight infants.
Topics: Antifungal Agents; Candidiasis; Clinical Trials as Topic; Cross Infection; Drug Administration Sched | 2005 |
Secular trends in nosocomial candidaemia in non-neutropenic patients in an Italian tertiary hospital.
Topics: Antifungal Agents; Candida; Candidiasis; Catheters, Indwelling; Cross Infection; Drug Resistance, Fu | 2005 |
Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study.
Topics: Anti-Infective Agents; Candida glabrata; Candidiasis; Case-Control Studies; Cross Infection; Female; | 2005 |
Survival of candida sepsis in extracorporeal membrane oxygenation.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Cross Infection; Endocarditis; Extracorporeal Memb | 2005 |
Empirical anti-Candida therapy among selected patients in the intensive care unit: a cost-effectiveness analysis.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Caspofungin; Cost-Benefit Ana | 2005 |
Fluconazole for the prevention of fungal infections: get ready, get set, caution.
Topics: Antifungal Agents; Candidiasis; Cross Infection; Fluconazole; Humans; Infant, Newborn; Infant, Prema | 2006 |
Prevalence, susceptibility profile for fluconazole and risk factors for candidemia in a tertiary care hospital in southern Brazil.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Brazil; Candida; Candidiasis; Child; | 2005 |
Epidemiological trends in nosocomial candidemia in intensive care.
Topics: Adult; Aged; Antifungal Agents; Candida; Candidiasis; Cross Infection; Drug Utilization; Female; Flu | 2006 |
Risk factors for candidemia-related mortality at a medical center in central Taiwan.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Anti-Bacterial Agents; APACHE; Candida; Candidiasis; | 2006 |
Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004.
Topics: Antifungal Agents; Birth Weight; Candida; Candidiasis; Cross Infection; Drug Resistance, Fungal; Flu | 2006 |
Evaluation of antifungals in the surgical intensive care unit: a multi-institutional study.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Cross Infection; Female; Fluconazole | 2006 |
Effect of fluconazole consumption on long-term trends in candidal ecology.
Topics: Antifungal Agents; Candida; Candidiasis; Cross Infection; Drug Utilization; Fluconazole; Fungemia; H | 2006 |
Nosocomial spondylodiskitis with epidural abscess and CSF fistula cured with quinupristin/dalfopristin and linezolid.
Topics: Acetamides; Anti-Bacterial Agents; Bacteria; Cerebrospinal Fluid; Combined Modality Therapy; Cross I | 2006 |
Epidemiology of candidemia in a Turkish tertiary care hospital.
Topics: Amphotericin B; Antifungal Agents; Blotting, Southern; Candida; Candidiasis; Cross Infection; DNA Fi | 2006 |
Neuroinfections and antimicrobials: do we need new molecules or new strategies?
Topics: Anti-Infective Agents; Brain Diseases; Candidiasis; Cross Infection; Drug Resistance, Microbial; Flu | 2007 |
Molecular epidemiology of Candida species isolated from clinical specimens of intensive care unit patients.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cluster Analysis; Cross Infection; DNA Fing | 2008 |
[Resistance to azolic compounds in clinical Trichophyton spp. strains].
Topics: Adult; Antifungal Agents; Cross Infection; Drug Resistance, Fungal; Drug Resistance, Multiple, Funga | 2007 |
Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit.
Topics: Adult; Aged; Antifungal Agents; Candida albicans; Candidiasis; Cross Infection; Female; Fluconazole; | 2008 |
Nosocomial Torulopsis glabrata fungemia with shock in a pregnant woman successfully treated with high doses of fluconazole and delivery of healthy child.
Topics: Adult; Candida; Cross Infection; Female; Fluconazole; Fungemia; Humans; Infant, Newborn; Pregnancy; | 1995 |
Variations in DNA subtype, antifungal susceptibility, and slime production among clinical isolates of Candida parapsilosis.
Topics: Amphotericin B; Candida; Candidiasis; Cross Infection; DNA, Fungal; Fluconazole; Flucytosine; Humans | 1995 |
Fungemia and colonization with nystatin-resistant Candida rugosa in a burn unit.
Topics: Amphotericin B; Burn Units; Burns; Candida; Candidiasis; Case-Control Studies; Cross Infection; Fluc | 1994 |
Failure of therapy with fluconazole for candidal endophthalmitis.
Topics: Adult; Amphotericin B; Candidiasis; Cross Infection; Endophthalmitis; Female; Fluconazole; Fungemia; | 1993 |
Neonatal Candida parapsilosis outbreak with a high case fatality rate.
Topics: Antifungal Agents; Candidiasis; Cohort Studies; Cross Infection; Female; Fluconazole; Hospital Morta | 1995 |
Emergence of fluconazole-resistant strains of Blastoschizomyces capitatus causing nosocomial infections in cancer patients.
Topics: Adult; Aged; Antifungal Agents; Cross Infection; Fluconazole; Humans; Male; Middle Aged; Neoplasms; | 1996 |
[Clinical aspects and prognosis of candidemia, a 6-year retrospective study].
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Female; Fluco | 1996 |
Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitals.
Topics: Antifungal Agents; Candidiasis; Censuses; Cross Infection; Cryptococcosis; Drug Resistance, Microbia | 1996 |
Hospital-acquired candidaemia: experience from a developing country.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Candidiasis; Child; Child, Preschool; Cr | 1997 |
Variations in DNA subtype and antifungal susceptibility among clinical isolates of Candida tropicalis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; DNA, Fungal; Electrophores | 1997 |
Systemic candidiasis in cardiac surgery patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Critical Care; Cross Inf | 1997 |
Molecular typing and fluconazole susceptibility of urinary Candida glabrata isolates from hospitalized patients.
Topics: Antifungal Agents; Candida; Candidiasis; Cross Infection; Fluconazole; Humans; Karyotyping; Microbia | 1997 |
[Candidemia: a never ceasing challenge].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cross Infection; Fluconazole; Fungemia; Humans; Retr | 1997 |
Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Cross Infection; Drug Resistance, Microbia | 1998 |
Candidemia: a nosocomial complication in adults with late-stage AIDS.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Cand | 1998 |
National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Drug Resistance, Microbial | 1998 |
National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Cross Infection; Drug Resistance, Microbial; Fluco | 1998 |
[Invasive pulmonary aspergillosis: a study of 33 cases].
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Cross Infection; Female; Fluconazo | 1998 |
Evidence for person-to-person transmission of Candida lusitaniae in a neonatal intensive-care unit.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Drug Resistance, Microbial | 1998 |
Hospital specificity, region specificity, and fluconazole resistance of Candida albicans bloodstream isolates.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Cross Infection; DNA Fingerprinting; DNA, Fungal; | 1998 |
Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital.
Topics: Adult; Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Candidiasis; Cross Infection; | 1999 |
Candida krusei sinusitis.
Topics: Alcoholism; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Fatal Outcome; | 1998 |
Management of asymptomatic candiduria.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Cross Infection; Fluconazo | 1999 |
An epidemic outbreak of Malassezia folliculitis in three adult patients in an intensive care unit: a previously unrecognized nosocomial infection.
Topics: Adult; Antifungal Agents; Cross Infection; Dermatomycoses; Disease Outbreaks; Fluconazole; Folliculi | 1999 |
Nosocomial candidaemias due to species other than Candida albicans in cancer patients. Aetiology, risk factors, and outcome of 45 episodes within 10 years in a single cancer institution.
Topics: Adrenal Cortex Hormones; Amphotericin B; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal A | 1999 |
Effects of fluconazole administration in critically ill patients: analysis of bacterial and fungal resistance.
Topics: Antifungal Agents; Bacterial Infections; Candidiasis; Case-Control Studies; Cohort Studies; Critical | 2000 |
Role of yeasts as nosocomial pathogens & their susceptibility to fluconazole & amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Candida; Cross Infection; Fluconazole; Humans; Microbial Sensitiv | 1999 |
[Candida albicans fungemia with pulmonary localization treated with fluconazole. A case report].
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Catheterization, Central Venous; Cross | 2000 |
Fungal colonization of haematological patients receiving cytotoxic chemotherapy: emergence of azole-resistant Saccharomyces cerevisiae.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cross Infection; | 2000 |
[Invasive Candida infection in surgical patients: a valid clinical entity].
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Cross Infection; Female; Fluconazole | 2000 |
Trends in frequency and susceptibilities of Candida glabrata bloodstream isolates at a university hospital.
Topics: Antifungal Agents; Candida; Colony Count, Microbial; Cross Infection; Drug Resistance, Microbial; Fl | 2001 |
Fungaemia in elderly patients.
Topics: Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candidiasis; Cross Infection; Female; Fl | 2001 |
[Fungal infections in intensive care units: a cross-survey].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cross Infection; Data Collection; Fluconazole; Flucy | 2001 |
Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
Topics: Adolescent; Adult; Antifungal Agents; Bacteremia; Bone Marrow Transplantation; Candida; Candidiasis; | 2001 |
Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use.
Topics: Antifungal Agents; Candida; Candidiasis; Cross Infection; Fluconazole; Fungemia; Humans; Incidence; | 2002 |
Nosocomial candidemia in a tertiary care hospital in Saudi Arabia.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Female; Fluconazole; Funge | 2002 |
[Candida infections in premature infants weighing less than 1,500 g. Mucocutaneous colonization and incidence of systemic infections].
Topics: Candidiasis, Chronic Mucocutaneous; Cesarean Section; Cross Infection; Cross-Sectional Studies; Drug | 1992 |
Treatment of candidemia in critically ill surgical patients with intravenous fluconazole.
Topics: Adolescent; Aged; Candidiasis; Cross Infection; Female; Fluconazole; Fungemia; Humans; Injections, I | 1992 |
[Systemic candidiasis in patients after kidney and heart transplantation].
Topics: Adult; Candidiasis; Cross Infection; Fluconazole; Heart Transplantation; Humans; Kidney Transplantat | 1990 |